The HPV Vaccine Saves Lives: Service members against cervical cancer

The Defense Department recommends male and female military service members, ages 17-26 years, receive an HPV vaccine series to generate a robust immune response to the quadrivalent human papillomavirus vaccine (HPV4). A new study of female ‪‎service members‬ that examined their immune response to the Human papillomavirus vaccine showed development of ‪‎antibodies in 80 to 99 percent of recipients against each of the four strains of the disease. ‪HPV‬ is a sexually transmitted virus that causes Cervical cancer and the most common sexually transmitted infection (‪‎STI‬) diagnosed in U.S. ‪‎military service members. Read "Study Finds Strong ‪‎Immune‬ Response to ‪HPV Vaccine‬ Among Female Service Members" to learn about the results of the study: http://ht.ly/SyNr3008th8 Link to infograph: http://health.mil/News/Gallery/Infographics/2016/05/16/The-HPV-Vaccine-Saves-LivesRead less